Ameritas Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5M Buy
13,778
+7,231
+110% +$7.39M 0.33% 72
2026
Q1
$6.02M Sell
6,547
-91
-1% -$92.3K 0.23% 100
2025
Q4
$7.13M Sell
6,638
-6
-0.1% -$5.74K 0.27% 86
2025
Q3
$5.07M Buy
6,644
+2,338
+54% +$1.74M 0.33% 60
2025
Q2
$3.36M Sell
4,306
-3,169
-42% -$2.46M 0.18% 124
2025
Q1
$5.96M Sell
7,475
-4,282
-36% -$3.56M 0.24% 88
2024
Q4
$9.08M Buy
11,757
+3,541
+43% +$2.93M 0.31% 63
2024
Q3
$7.28M Sell
8,216
-6,237
-43% -$5.61M 0.31% 69
2024
Q2
$13.1M Buy
14,453
+1,183
+9% +$946K 0.49% 45
2024
Q1
$10.1M Buy
13,270
+1,906
+17% +$1.36M 0.42% 49
2023
Q4
$7.65M Sell
11,364
-769
-6% -$449K 0.42% 54
2023
Q3
$6.96M Buy
12,133
+6,764
+126% +$3.49M 0.35% 54
2023
Q2
$2.43M Sell
5,369
-2,593
-33% -$1.09M 0.31% 72
2023
Q1
$2.86M Sell
7,962
-1,281
-14% -$432K 0.14% 139
2022
Q4
$3.38M Buy
9,243
+1,804
+24% +$640K 0.16% 132
2022
Q3
$2.4M Buy
7,439
+113
+2% +$35.8K 0.14% 145
2022
Q2
$2.38M Sell
7,326
-231
-3% -$69.3K 0.14% 157
2022
Q1
$2.16M Sell
7,557
-337
-4% -$86.7K 0.08% 201
2021
Q4
$2.18M Buy
+7,894
New +$2M 0.08% 201

Other funds holding LLY

Ameritas Advisory Services's LLY Position: Q2 2026 in Review

Ameritas Advisory Services increased its Eli Lilly (LLY) stake by 110% in Q2 2026, buying an estimated $7.39M and bringing the position to 13,778 shares worth $16.5M. The position accounts for 0.33% of the portfolio, ranked #72.

Ameritas Advisory Services first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ameritas Advisory Services held 13,778 shares of Eli Lilly worth $16.5M as of Q2 2026.
  • Ameritas Advisory Services bought 7,231 Eli Lilly shares in Q2 2026, an estimated $7.39M.
  • Eli Lilly made up 0.33% of Ameritas Advisory Services's portfolio in Q2 2026, its #72 holding.
  • Ameritas Advisory Services first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.